MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0009855
Lederle Pharma Private Limited
Lederle Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.44 Cr
▲ 77% YoY
Net loss · FY 2025
₹89,668
Net margin -0.2%
EBITDA · FY 2025
₹3,459
EBITDA margin 0%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.25 Cr
Issued & subscribed
Open charges
₹1.25 Cr
Secured borrowings
Company age
19 yrs
Est. 2007
Directors on board
3
As per MCA filings
About Lederle Pharma Private Limited
Data last updated:
Lederle Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 September 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PTC168221. Its GSTIN is 07AABCL4399R1ZN (Delhi).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.25 Cr. It is led by directors including Mehul Surana and Ajay Kumar Surana.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 75 Second Floor Block – A Kirti Nagar Delhi, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.44 Cr, a growth of 77% compared to the previous year. For the same year it recorded a net loss of ₹89,668 (net margin -0.2%) and EBITDA of ₹3,459 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 18% over five years.
As per MCA filings, the company has open charges of ₹1.25 Cr on record. Court records list 17 cases involving the company, including 13 filed by the company and 4 filed against it; 13 cases are pending.
Lederle Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0009855). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233DL2007PTC168221
Registration Number 168221
Incorporation Date 14 September 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0009855
CIN history
Lederle Pharma has one previous CIN (Corporate Identification Number): U24233DL2007PLC168221. The current CIN is U24233DL2007PTC168221, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233DL2007PTC168221 | Current |
| U24233DL2007PLC168221 | Previous |
Recognitions & Rankings of Lederle Pharma
Contact details
Lederle Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressA – 75 Second Floor Block – A Kirti Nagar Delhi, Delhi, India – 110015
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Lederle Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Lederle Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lederle Pharma Private Limited, buy the company report.
Financials of Lederle Pharma Private Limited
FY 2025 filings availableLederle Pharma Private Limited reported revenue of ₹4.44 Cr (up 77% YoY) for FY 2025.
Revenue · FY 2025
₹4.44 Cr ▲ 77%
Net loss · FY 2025
₹89,668 margin -0.2%
EBITDA · FY 2025
₹3,459 margin 0%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 77%
3 years · compounded
▲ 26%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 100%
3 years · compounded
▼ 63%
5 years · compounded
▲ 15%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 77% growth in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3,459 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹89,668 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lederle Pharma Private Limited, buy the company report.
Board of directors of Lederle Pharma Private Limited
Lederle Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehul Surana | Director | 12 Jul 2021 | 5 Years 3 Months | Current |
| Ajay Kumar Surana Also directs: Jas Leasing and Property Developers Limited., Nuvilife Global LLP, Eastern Capulations Private Limited and 3 more | Director | 01 Jul 2017 | 9 Years 3 Months | Current |
| Sanjay Surana Also directs: Ultimate Cloud LLP, Jas Leasing and Property Developers Limited., White Knight Real Estate Private Limited and 2 more | Director | 26 Oct 2007 | 19 Years 0 Months | Current |
Peer comparison
Lederle Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Varek Pharmasol Private Limited | ₹4.44 Cr (FY 2024) | 221.0% | Mathura, Uttar Pradesh, India | |||
| Lederle Pharma Private Limitedthis company | ₹4.44 Cr (FY 2025) | -₹89,668 | -0.2% | 77.0% | Delhi, India | |
| Kansas Drugs & Pharmaceuticals Pvt.Ltd. | ₹4.43 Cr (FY 2023) | 11.0% | Kolkata, West Bengal, India | |||
| Kountry Pharmacare Private Limited | ₹4.43 Cr (FY 2025) | 574.0% | Meerut, Uttar Pradesh, India | |||
| Skysun Lifesciences Private Limited | ₹4.43 Cr (FY 2024) | 29.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Lederle Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.25 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jun 2010 | 10225664 | The Nainital Bank Limited | ₹1.25 Cr | Open |
Total charge records: 1 View all charges
Legal cases
Lederle Pharma Private Limited has 17 court cases on record: 13 filed by Lederle Pharma, 4 filed against it. 13 cases are pending and 4 are disposed.
Total cases
17
Filed by the company
13
Filed against the company
4
Pending
13
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 2 | 13 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Commercial suit | Filed by the company against Pharmex Criticare LLP | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against Ms Priyanjul Pharmaceutical Pvt Ltd | Pending |
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Dr Reddys Laboratories Ltd | Disposed |
| District court, Central, Delhi | Commercial suit | Filed by the company against an individual | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Lederle Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lederle Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lederle Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCL4399R1ZN | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lederle Pharma Private Limited, buy the company report.
Recent activity
Lederle Pharma Private Limited has 12 board changes on record since 2007: 3 appointments and 9 cessations. The latest: Deepanjay Jain ceased to be Director on 13 Sep 2021.
AGM
Lederle Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Lederle Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Deepanjay Jain ceased to be Director.
Appointed
Mehul Surana was appointed as Director.
Ceased
Rakesh Handa ceased to be Director.
Ceased
Ajay Kumar Surana ceased to be Additional Director.
Ceased
Urmila Surana ceased to be Additional Director.
Ceased
Deepak Goswami ceased to be Director.
Ceased
Sushma Sharma ceased to be Director.
Appointed
Ajay Kumar Surana was appointed as Director.
Ceased
Rajesh Sharma ceased to be Managing Director.
Ceased
Suraj Mal Surana ceased to be Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Lederle Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 September 2007 (19+ years old) and is registered under CIN U24233DL2007PTC168221.
Lederle Pharma has 3 current directors:
- Mehul Surana - Director
- Ajay Kumar Surana - Director
- Sanjay Surana - Director
The latest financial statements of Lederle Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lederle Pharma is 07AABCL4399R1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Lederle Pharma is U24233DL2007PTC168221. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lederle Pharma has 17 court cases on record: 13 filed by the company and 4 filed against it. 13 are pending. Most are in the district courts.
Lederle Pharma was incorporated on 14 September 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lederle Pharma by revenue are Varek Pharmasol Private Limited, Kansas Drugs & Pharmaceuticals Pvt.Ltd, Kountry Pharmacare Private Limited, Skysun Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Deepanjay Jain ceased to be Director on 13 Sep 2021. Mehul Surana was appointed as Director on 12 Jul 2021. Rakesh Handa ceased to be Director on 16 Jun 2021. Lederle Pharma has 12 board changes on record in total.
Yes, Lederle Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0009855).
The registered office of Lederle Pharma is at A – 75 Second Floor Block – A Kirti Nagar Delhi, Delhi, India – 110015.